Skip to main content
. 2018 Jun 21;16(3):3140–3144. doi: 10.3892/ol.2018.9007

Figure 3.

Figure 3.

The clinical value of miRNA-29b and miRNA-30c in the diagnosis of PCa miRNA-29b AUC, 0.924; 95% CI, 0.824–0.967, and miRNA-30c AUC, 0.944; 95% CI, 0.798–0.972. PCa, prostate cancer.